Cargando…
Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus
BACKGROUND: Dipeptidyl peptidase-4 inhibitors (DPP-4i) provide a unique antihyperglycemic effect by regulating incretin peptides in type 2 diabetes mellitus (T2DM) patients who are inadequately controlled with insulin therapy. The aim of this study was to investigate the impact of DPP-4i on leptin c...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390252/ https://www.ncbi.nlm.nih.gov/pubmed/34446063 http://dx.doi.org/10.1186/s13098-021-00703-x |